Patents by Inventor Benjamin Ebert

Benjamin Ebert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8530443
    Abstract: The invention provides methods of treating certain blood related disorders, in particular, thrombocytopenia and anemia comprising increasing miR-150 expression or inhibiting miR-150 in progenitor cells respectively.
    Type: Grant
    Filed: October 16, 2012
    Date of Patent: September 10, 2013
    Assignees: The General Hospital Corporation, Massachusetts Institute of Technology, Dana-Farber Cancer Institute, Inc.
    Inventors: Jun Lu, Shangqin Guo, Benjamin Ebert, David Scadden, Todd Golub
  • Publication number: 20130039895
    Abstract: The invention provides methods of treating certain blood related disorders, in particular, thrombocytopenia and anemia comprising increasing miR-150 expression or inhibiting miR-150 in progenitor cells respectively.
    Type: Application
    Filed: October 16, 2012
    Publication date: February 14, 2013
    Applicants: THE GENERAL HOSPITAL CORPORATION, DANA-FARBER CANCER INSTITUTE, INC., MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Jun Lu, Shangqin Guo, Benjamin Ebert, David Scadden, Todd Golub
  • Publication number: 20130005792
    Abstract: The invention relates to expression profiles of HIV-specific T-cells and their methods of use, including but not limited to treatment of HIV, increasing T-cell function and/or survival in HIV infected subjects, monitoring HIV disease progression and classifying HIV infected subjects as controllers or chronic progressors.
    Type: Application
    Filed: April 20, 2012
    Publication date: January 3, 2013
    Applicants: Dana-Farber Cancer Institute, The General Hospital Corporation, Brigham & Women's Hospital
    Inventors: W. N. Haining, Benjamin Ebert, Bruce Walker
  • Publication number: 20090202493
    Abstract: The invention provides methods of treating certain blood related disorders, in particular, thrombocytopenia and anemia comprising increasing miR-150 expression or inhibiting miR-150 in progenitor cells respectively.
    Type: Application
    Filed: January 30, 2009
    Publication date: August 13, 2009
    Applicants: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS INSTITUTE OF TECHNOLOGY, DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Jun Lu, Shangqin Guo, Benjamin Ebert, David Scadden, Todd Golub